Arcutis Biotherapeutics closes $94.5mm Series C round

14:40 EST 7 Nov 2019 | Elsevier Business Intelligence

Arcutis Biotherapeutics Inc. (immuno-dermatology) closed a $94.5mm Series C round led by HBM Healthcare (added a board member...

Original Article: Arcutis Biotherapeutics closes $94.5mm Series C round


More From BioPortfolio on "Arcutis Biotherapeutics closes $94.5mm Series C round"

Quick Search

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...